Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-2,182
Closed -$135K 70
2021
Q3
$135K Buy
2,182
+838
+62% +$55.2K 0.09% 80
2021
Q2
$114K Hold
1,344
0.08% 84
2021
Q1
$107K Sell
1,344
-460
-25% -$29.9K 0.08% 91
2020
Q4
$105K Sell
1,804
-616
-25% -$29K 0.07% 85
2020
Q3
$82K Buy
2,420
+320
+15% +$12.1K 0.06% 89
2020
Q2
$97K Sell
2,100
-1,270
-38% -$35.3K 0.08% 77
2020
Q1
$53K Hold
3,370
0.05% 41
2019
Q4
$92K Buy
3,370
+1,200
+55% +$32.1K 0.07% 83
2019
Q3
$64K Buy
+2,170
New +$64.6K 0.04% 102

Other funds holding AFMD

HighVista Strategies's AFMD Position: Q4 2021 in Review

HighVista Strategies sold out of Affimed (AFMD) in Q4 2021, closing a stake of 2,182 shares — an estimated $135K sold.

HighVista Strategies first reported a position in AFMD in Q3 2019 and held it in 9 quarters. The position peaked at $135K in Q3 2021. 123 funds tracked by Wall St. Rank hold AFMD as of Q4 2021.

  • HighVista Strategies reported no remaining Affimed position as of Q4 2021 after selling out during the quarter.
  • HighVista Strategies sold 2,182 Affimed shares in Q4 2021, an estimated $135K.
  • HighVista Strategies first reported a position in Affimed in Q3 2019 and held it in 9 quarters.
  • HighVista Strategies's Affimed position peaked at $135K in Q3 2021.
  • 123 funds tracked by Wall St. Rank held Affimed as of Q4 2021.

Based on HighVista Strategies's 13F filing for Q4 2021, filed 14 Feb 2022.